Arbutus Biopharma
ABUS
ABUS
48 hedge funds and large institutions have $26.5M invested in Arbutus Biopharma in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-11
Holders Change %
-18.64%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
17
Reduced
10
Closed
18
Calls
$749K
Puts
$13K
Net Calls
+$736K
Net Calls Change
+$235K
Top Buyers
| 1 |
CAC
Cowen and Company
New York
|
+$3.44M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.45M |
| 3 |
Goldman Sachs
New York
|
+$1.87M |
| 4 |
RI
RTW Investments
New York
|
+$1.21M |
| 5 |
HP
Hound Partners
New York
|
+$580K |
Top Sellers
| 1 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$10.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.27M |
| 3 |
Jennison Associates
New York
|
-$2.61M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.03M |
| 5 |
Bank of New York Mellon
New York
|
-$713K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Simplex Trading
Chicago,
Illinois
| – | -$120K | -43,344 | Closed |
|
|
WG
52
Winton Group
London,
United Kingdom
| – | -$118K | -42,373 | Closed |
|
|
OAM
53
Oxford Asset Management
Oxford,
United Kingdom
| – | -$61K | -22,051 | Closed |
|
|
BFM
54
Boothbay Fund Management
New York
| – | -$59K | -21,261 | Closed |
|
|
PP
55
Paloma Partners
Greenwich,
Connecticut
| – | -$55K | -19,674 | Closed |
|
|
ARTA
56
A.R.T. Advisors
New York
| – | -$30K | -10,780 | Closed |
|
57
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$4K | -1,742 | Closed |
|
|
CSS
58
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$2K | -895 | Closed |
|
59
Barclays
London,
United Kingdom
| – | -$1K | -360 | Closed |
|
|
PAM
60
Panagora Asset Management
Boston,
Massachusetts
| – | -$1K | -350 | Closed |
|